SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-034763
Filing Date
2020-07-30
Accepted
2020-07-30 18:41:50
Documents
64
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q apls-10q_20200630.htm   iXBRL 10-Q 2703868
2 EX-31.1 apls-ex311_7.htm EX-31.1 18437
3 EX-31.2 apls-ex312_6.htm EX-31.2 17552
4 EX-32.1 apls-ex321_9.htm EX-32.1 8563
5 EX-32.2 apls-ex322_8.htm EX-32.2 8572
  Complete submission text file 0001564590-20-034763.txt   7972846

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA apls-20200630.xsd EX-101.SCH 50312
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE apls-20200630_cal.xml EX-101.CAL 43832
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE apls-20200630_def.xml EX-101.DEF 161354
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE apls-20200630_lab.xml EX-101.LAB 372232
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE apls-20200630_pre.xml EX-101.PRE 292051
11 EXTRACTED XBRL INSTANCE DOCUMENT apls-10q_20200630_htm.xml XML 1333955
Mailing Address 100 FIFTH AVENUE WALTHAM MA 02451
Business Address 100 FIFTH AVENUE WALTHAM MA 02451 617-977-5700
Apellis Pharmaceuticals, Inc. (Filer) CIK: 0001492422 (see all company filings)

IRS No.: 271537290 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38276 | Film No.: 201061343
SIC: 2834 Pharmaceutical Preparations